In addition, Axl inhibition in tumor-bearing mice impairs tumor cell-induced angiogenesis and decreases immunohistochemical staining of the endothelial cell marker CD31 in the tumor [49,50,51,52]. This evidence concerns the gene AXL and neoplasm.